Research Article
SOX8 Knockdown Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting the Notch Signaling Pathway
Table 1
Primary antibodies for Western blotting assay.
| Primary antibodies | Concentration | Company | Catalog number |
| SOX8 | 1 : 2,000 | Abcam | ab104245 | Notch4 | 1 : 1,000 | Santa Cruz | SC-383993 | Hes5 | 1 : 2,000 | Abcam | ab25374 | E-Cadherin | 1 : 2,000 | CST | 14472 | N-Cadherin | 1 : 2,000 | CST | 13116 s | Vimentin | 1 : 1,000 | CST | 5741 s | Zeb-1 | 1 : 2,000 | CST | 70512 s | Hey1 | 1 : 2,000 | Abcam | ab22641 | Hey2 | 1 : 1,000 | Abcam | ab167280 | P21 | 1 : 2,000 | Abcam | ab109520 | c-Myc | 1 : 1,000 | Abcam | ab32072 | Cyclin E1 | 1 : 1,000 | Abcam | ab33911 | Cyclin D1 | 1 : 2,000 | Abcam | ab16663 | Cyclin D3 | 1 : 1,000 | Abcam | abSP207 | BAX | 1 : 2,000 | Abcam | ab53145 | BAK | 1 : 2,000 | CST | 12105T | BCL2 | 1 : 2,000 | CST | 4223T | BCL-xl | 1 : 1,000 | CST | 2764T | β-Catenin | 1 : 1,000 | Abcam | ab223075 | p-β-Catenin | 1 : 500 | Abcam | ab277785 | GAPDH | 1 : 1,000 | CST | 5174s |
|
|
Abcam: Abcam Cambridge, UK; Santa Cruz: Santa Cruz Biotechnology, Inc., USA; CST: Cell Signaling Technology, USA.
|